Davis Blaine 4
4 · ArTara Therapeutics, Inc. · Filed Feb 11, 2020
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-11+94,000→ 94,000 totalExercise: $37.30Exp: 2030-02-10→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vesting upon Mr. Davis's completion of one year of service measured from the grant date and the balance of the shares vesting monthly thereafter for the next three years.